Diabetes Clinical Trials in North Carolina

Showing 521-540 of 612 trials

A Trial of TT223 in Patients With Type 2 Diabetes Who Are Taking Metformin and/or Thiazolidinedione

NCT00743002

This trial is designed to show the effect of treatment with TT223 or placebo on blood glucose control after 12 weeks of treatment with a 6 month follow-up. TT223 is administered by injection once daily to patients currently treated with Metformin and/or Thiazolidinedione.

Diabetes Mellitus, Type 2

OPKO Health, Inc.87 participantsStarted Aug 2008

Artesia, California, United States • Los Angeles, California, United States • Santa Ana, California, United States +17 more locations

TERMINATEDPhase 45.4 miles

Study to Evaluate the Efficacy and Safety of the Combination of Valturna and Amlodipine or Valturna and Chlorthalidone Versus Valturna Alone in Patients With Stage 2 Hypertension and Diabetes

NCT01368536

This was a study to assess the safety and efficacy of Valturna and amlodipine or Valturna and chlorthalidone when compared to Valturna alone in patients with stage 2 hypertension and diabetes mellitus 2.

HypertensionStage 2 HypertensionDiabetes

Novartis Pharmaceuticals975 participantsStarted May 2011

Athens, Alabama, United States • Florence, Alabama, United States • Huntsville, Alabama, United States +94 more locations

A Trial of TT223 in Patients With Type 2 Diabetes Who Are Taking Metformin and/or Thiazolidinedione

Study to Evaluate the Efficacy and Safety of the Combination of Valturna and Amlodipine or Valturna and Chlorthalidone Versus Valturna Alone in Patients With Stage 2 Hypertension and Diabetes

Diabetes Trials in Other Cities

Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus

Glycemic Control, Safety and Tolerability of TC-6987 Monotherapy in Type 2 Diabetes Mellitus

Family PALS (PArtners in Lifestyle Support)

Efficacy and Safety of B I1356 (Linagliptin) vs. Placebo Added to Metformin Background Therapy in Patients With Type 2 Diabetes

Study of Safety and Efficacy of PF-04991532 in Subjects With Type 2 Diabetes

Efficacy and Safety in Patients With Type 2 Diabetes Mellitus, Cardiovascular Disease and Hypertension

The CANTATA-MSU Trial (CANagliflozin Treatment And Trial Analysis - Metformin and SUlphonylurea)

Fasiglifam in Type 2 Diabetic Subjects With Chronic Kidney Disease Stage 4 or 5 on Hemodialysis

Multicenter Worksite Nutrition Study

Impact of a Diabetes Risk Score on Lifestyle Education and Patient Adherence

Interferon-Alpha for Diabetes Mellitus Type 1

Effect Of Paricalcitol (Zemplar) On Endothelial Function And Inflammation In Type 2 Diabetes And Chronic Kidney Disease

Open Label, 4 Week Study of ITCA 650 in Adults With Type 2 Diabetes

Exploratory Study to Access the Metabolic Effects of Ranolazine in Subjects With Type 2 Diabetes Mellitus When Added to Ongoing Non-insulin Antidiabetic Therapy

A 6 Week Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of GK1-399 in Type 2 Diabetes

Diabetes and Periodontal Therapy Trial

A Study of the Safety, Pharmacokinetics, and Pharmacodynamics of CNTO 3649 in Healthy Adults and Patients With Type 2 Diabetes Mellitus

Insulins Glargine and gluLisine strAtegy Versus Premixed Insulin strAteGy: a cOmparative Study

Other Conditions in North Carolina